Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such as EBC MAIN (Left Main Study of the European Bifurcation Club) and EBC TWO (European Bifurcation Coronary Study Two) have shown that, in the treatment of true left main coronary artery (LMCA) lesions or large coronary bifurcations, the clinical outcomes with PS are comparable to those obtained with an initial two-stent strategy.

Provisional stenting requires two fundamental steps: stent implantation in the main vessel, followed by post-dilation of the proximal stented segment using the proximal optimization technique (POT). However, the optimal treatment strategy for the side branch is still uncertain. Currently, there are two main sequences: POT-kissing-POT (PKP) and POT-Side-POT (PSP). In preclinical studies, the PSP sequence has proven to be more effective in preserving stent diameter in the proximal segment, while the PKP sequence has shown better stent expansion in the distal segment.

The objective of this prospective, randomized study was to compare the PKP and PSP sequences using optical coherence tomography (OCT) to assess the differences in stent configuration.

The primary endpoint (PEP) was minimum stent expansion (MSE) in the distal main vessel (MV) segment. Secondary endpoints (SEPs) included MSE in other segments, maximum malapposition distance, and malapposition area. Other evaluated SEPs were the stent under-expansion rate, malapposition, dissection at the proximal stent edge, tissue prolapse, intracoronary thrombus, and side-branch ostium dissection or in-stent dissection.

Read also: Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry.

Between 2023 and 2024, operators performed a total of 60 procedures, randomized 30:30 for each sequence. The mean patient age was 70 years. In post-procedural OCT, MSE at the distal MV segment was significantly higher with the PKP sequence compared to the PSP sequence (99.3±12.7% vs. 83.8±19.5%; p <0.001). Other relevant findings included a higher rate of malapposition in the bifurcation core and the distal MV segment with PSP, as well as better side-branch structure with PKP. There were no significant differences in stent eccentricity between PSP and PKP in any of the analyzed segments.

Conclusion

This is the first randomized study comparing different provisional stenting sequences. The findings suggest that the use of the PKP sequence is associated with better stent configuration in the bifurcation core and distal MV segment, with higher expansion and lower malapposition rates compared to the PSP sequence. However, further studies are needed to validate these results in larger and more diverse populations to optimize stenting strategies for bifurcation lesions.

Original Title: Comparison of stent geometry achieved by different side-branch ballooning techniques for bifurcation provisional stenting: THE CRABBIS TRIAL.

Reference: Francesco Bianchini, MD et al JACC  2025.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...